1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for the United States
Continuous Renal Replacement Therapy (CRRT) Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in the United States
Continuous Renal Replacement Therapy (CRRT) Market
4. United States Continuous Renal
Replacement Therapy (CRRT) Market by Product
4.1. Disposables
4.1.1. Bloodline Sets (Tubing Sets)
4.1.2. Hemofilters
4.1.3. Others
4.2. Systems
4.3. Dialysates and Replacement Fluids
5. United States Continuous Renal
Replacement Therapy (CRRT) Market by Therapy
5.1. Non-renal
5.2. Renal
6. United States Continuous Renal
Replacement Therapy (CRRT) Market by Modality
6.1. Slow Continuous Ultrafiltration (SCUF)
6.2. Continuous Venovenous Hemofiltration (CVVH)
6.3. Continuous Venovenous Hemodialysis (CVVHD)
6.4. Continuous Venovenous Hemodiafiltration
(CVVHDF)
7. United States Continuous Renal
Replacement Therapy (CRRT) Market by End-user
7.1. Hospitals
7.2. Dialysis Clinics
7.3. Homes
7.4. Others
8. Company Profiles
8.1. Manufacturer's & Suppliers
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.1.4. Company 4
8.1.5. Company 5
8.2. Dealer's / Distributor's Profile
8.2.1. Dealer's / Distributor's 1
8.2.2. Dealer's / Distributor's 2
8.2.3. Dealer's / Distributor's 3
8.2.4. Dealer's / Distributor's 4
8.2.5. Dealer's / Distributor's 5
8.2.6. Dealer's / Distributor's 6
8.2.7. Dealer's / Distributor's 7
8.2.8. Dealer's / Distributor's 8
8.2.9. Dealer's / Distributor's 9
8.2.10. Dealer's / Distributor's 10
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for the United States
Continuous Renal Replacement Therapy (CRRT) Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in the United States
Continuous Renal Replacement Therapy (CRRT) Market
4. United States Continuous Renal
Replacement Therapy (CRRT) Market by Product
4.1. Disposables
4.1.1. Bloodline Sets (Tubing Sets)
4.1.2. Hemofilters
4.1.3. Others
4.2. Systems
4.3. Dialysates and Replacement Fluids
5. United States Continuous Renal
Replacement Therapy (CRRT) Market by Therapy
5.1. Non-renal
5.2. Renal
6. United States Continuous Renal
Replacement Therapy (CRRT) Market by Modality
6.1. Slow Continuous Ultrafiltration (SCUF)
6.2. Continuous Venovenous Hemofiltration (CVVH)
6.3. Continuous Venovenous Hemodialysis (CVVHD)
6.4. Continuous Venovenous Hemodiafiltration
(CVVHDF)
7. United States Continuous Renal
Replacement Therapy (CRRT) Market by End-user
7.1. Hospitals
7.2. Dialysis Clinics
7.3. Homes
7.4. Others
8. Company Profiles
8.1. Manufacturer's & Suppliers
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.1.4. Company 4
8.1.5. Company 5
8.2. Dealer's / Distributor's Profile
8.2.1. Dealer's / Distributor's 1
8.2.2. Dealer's / Distributor's 2
8.2.3. Dealer's / Distributor's 3
8.2.4. Dealer's / Distributor's 4
8.2.5. Dealer's / Distributor's 5
8.2.6. Dealer's / Distributor's 6
8.2.7. Dealer's / Distributor's 7
8.2.8. Dealer's / Distributor's 8
8.2.9. Dealer's / Distributor's 9
8.2.10. Dealer's / Distributor's 10